BRIEF-Cardinal Health Q4 Adjusted EPS USD 2.91 Vs. IBES Estimate USD 2.42
Reuters2026/08/11 10:46Aug 11 (Reuters) - Cardinal Health Q4 EPS USD 1.7.
- Q4 revenue USD 63,700 million vs. IBES estimate USD 65,029 million
- Q4 net income USD 398 million
- outlook FY adjusted EPS USD 12.4-12.6 vs. IBES estimate USD 12
- Outlook FY adjusted EPS USD 12.4-12.6
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application
Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.
Enovis CEO Damien McDonald acquires $249,620 of common shares
Outfront Media EVP Mark Emilio Bonanni sells 3,385 shares for $100,950.7
ERock files initial beneficial ownership statement for Walter Thomas McAndrew Jr
Crypto prices
More
